BLOODBORNE PATHOGENS EXPOSURE REPORT

Similar documents
OCCUPATIONAL HEALTH, DISABILITY AND LEAVE SECTOR MEASURES TO MINIMIZE EXPOSURE TO BLOODBORNE PATHOGENS AND POST-EXPOSURE PROPHYLAXIS POLICY

Bloodborne Pathogens. Scott Anderson CCEMTP. Materials used with permission from the Oklahoma State University

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

A P P E N D I X SAMPLE FORMS

POLICY 08:18:00 BLOODBORNE PATHOGENS CONTROL PLAN

Appendix 3 Exposure Incident Report Form

Exposure. What Healthcare Personnel Need to Know

OSHA s Bloodborne Pathogens Standard

Body Fluid Exposure:

Roger Williams University. Bloodborne Pathogens Exposure Control Plan

POSTEXPOSURE PROPHYLAXIS

WHY ARE WE HERE? OSHA BB Pathogen standard. The more you know, the better you will perform in real situations!

Blood borne Pathogens

AUBURN UNIVERSITY HARRISON SCHOOL OF PHARMACY

Environmental Health and Safety Offices BLOODBORNE PATHOGENS

OCCUPATIONAL EXPOSURE TO BLOODBORNE PATHOGENS (29 CFR )

Guidelines for Managing Exposures to Blood Borne Pathogens

OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA)

Didactic Series. Updated Post-Exposure Prophylaxis (PEP) Guidelines. Daniel Lee, MD UCSD Medical Center, Owen Clinic January 9, 2014

Burton Hospitals NHS Foundation Trust. Corporate / Directorate. Clinical / Non Clinical. Department Responsible for Review:

Bloodborne Pathogens

Bloodborne Pathogens (BBPs) Louisiana Delta Community College

DISEASES SPREAD THROUGH BLOOD AND BODY FLUIDS

Biohazard - Anything that is harmful or potentially harmful to man, other species or the environment.

Post-Exposure Prophylaxis

Title: Post Exposure Prophylaxis Page 1 of 8 Policy No: 1 CLN 010 Effective Date 04/15/11

Managing Bloodborne Pathogens Exposures

Bloodborne Pathogens. Updated

Patient Information Sheet

Definitions. This plan. membrane, These are. additions and. and. weeping a source of. withstand the. demands of to or from a

Management Plan For Control of Blood-borne Pathogens, Infectious Wastes and Other Potentially Hazardous Biological Agents

MUSC Occupational Blood Borne Pathogen Protocol Off-Campus Procedure Packet

This pamphlet describes how all school employees, regardless of job assignment, can minimize the risk of exposure to viral hepatitis.

UNIVERSITY OF KENTUCKY HEALTH CARE COLLEGES POLICY ON EDUCATIONAL EXPOSURE TO BLOOD BORNE PATHOGENS

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

DO YOU WORK AROUND BLOOD OR BODY FLUIDS? Cal/OSHA s New Rules

Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis

HEPATITIS A, B, AND C

Blood Borne Pathogen Exposure Control Plan Checklist

Bloodborne Pathogens Exposure Incident Reporting Kit

Are you Hep C aware? awareness information support prevention To find out more visit

Bloodborne Pathogens. San Diego Unified School District Nursing & Wellness Program August 2013

Bloodborne Pathogens Program Revised July,

GUIDELINES FOR THE MANAGEMENT OF A PERCUTANEOUS OR SEXUAL EXPOSURE TO BLOODBORNE PATHOGENS DEPARTMENT OF HEALTH AND WELLNESS PRINCE EDWARD ISLAND

FLORENCE TOWNSHIP BOARD OF EDUCATION FILE CODE: / Florence, New Jersey

6.0 Infectious Diseases Policy: Student Exposure Control Plan

Manual Document Page Issue Date TABLE OF CONTENTS

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES

OUTLINE POST EXPOSURE PROPHYLAXIS (PEP) OCCUPATIONAL RISK OF VIRAL TRANSMISSION WITH SHARP INJURY FROM INFECTED SOURCE:

MARIST COLLEGE. Bloodborne Pathogens Standard (29 CFR )

Exposure Control Plan Bloodborne Infectious Diseases

Mock OSHA Inspection:

THE A, B, C S OF HEPATITIS. Matt Eidem, M.D. Digestive Health Associates of Texas 1600 Coit Road Suite #301 Plano, Texas (972)

Prevention of transmission of HIV and other bloodborne viruses in healthcare and post exposure prophylaxis. John Ferguson, UPNG 2012

Use and Disposal of Sharps

Corporate Safety Infection Prevention Employee Health

UCSF Communicable Disease Surveillance and Vaccination Policy

Bloodborne Pathogens Annual Training Module

Mercyhurst University Athletic Training Program Bloodborne Pathogens Exposure Control Plan

HIV/AIDS: General Information & Testing in the Emergency Department

POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING

School of Nursing Blood Borne Pathogen Exposure and Injury to Student Policy and Procedure

BLOODBORNE PATHOGENS EXPOSURE CONTROL PROGRAM

ALBERTA IMMUNIZATION POLICY GUIDELINES

BLOODBORNE PATHOGENS IN SCHOOLS

Registered Nursing Health Requirements Checklist

Leader s Guide E4017. Bloodborne Pathogens: Always Protect Yourself

University Health Services Health and Safety EXPOSURE CONTROL PLAN

Use the steps below to complete the CertifiedBackground (CB) electronic health record tracking process.

Bloodborne Pathogens Exposure Control Plan

Bloodborne Exposure Incident Report -Questionnaire and Report-

Blood/Bodily Fluid Exposure and Needlestick Injury Policy Statement & HIV PEP Kit Dispensing Guideline

JAC-CEN-DEL COMMUNITY SCHOOLS BLOODBORNE PATHOGENS UNIVERSAL PRECAUTIONS A BACK TO SCHOOL TRADITION

1) Giving patient access and control over their health information

The methods of implementation of these elements of the standard are discussed in the subsequent pages of this ECP.

Needle-Stick Policy.

& OSHA STANDARDS TARGET GROUP: Core Campus Nursing Students SECTION: Academic

Instructions for Clinical Rotation Abroad

CANCER OF THE LIVER HEPATOCELLULAR CARCINOMA

EXPOSURE CONTROL PLAN (sample) 1 Child Care Directors and Employers

HIV post exposure prophylaxis (PEP) for those working internationally

Instructions for Abroad Clinical Rotation

WEST VIRGINIA UNIVERSITY EXPOSURE CONTROL PLAN FOR NON-HOSPITAL PERSONNEL

(C) Deep injury and those caused by hollow bore needles, where more potential transference of blood is involved.

Health Care Worker Health and Safety: Preventing Needlestick Injury and Occupational Exposure to Bloodborne Pathogens

University of St. Francis

POST-EXPOSURE PROPHYLAXIS (HIV, HEP B, HEP C)

Reference:

The Hepatitis B virus (HBV)

Infection Prevention and Control Policy Prevention and Management of Occupational Exposure to Blood-Borne Viruses (BBVs) and Post-Exposure Prophylaxis

Protocol for Needle Stick Injuries Occurring to NY Medical College Students In Physicians Offices

Revised February 5, 2014

Attachment D Infection Control Policy METHODS OF IMPLEMENTATION AND CONTROL

Guide to the European Union

Viral Hepatitis A, B, and C

Nurse Aide Training Program Application Checklist

english facts about hepatitis A, B and C

GENERAL INFORMATION. Hepatitis B Foundation - Korean Chapter Pg. 3

Blood-borne viruses in the workplace Guidance for employers and employees

Transcription:

BLOODBORNE PATHOGENS EXPOSURE REPORT In case of exposure to bloodborne pathogens, complete this form and return to the Infection Control Nurse within 24 hours for post-exposure evaluation. If other persons were involved, attach additional copies of this form for each person involved. Date of Report: / / Time of Report: Name (Last, First, M.I.): Sex: Male Female Employee I.D. Number: Address (Local): Work Phone: Date of Birth: Home Phone: Status at time of exposure: Employee Student Faculty Other: (Explain) Job Title: Duties related to exposure: Has the exposed individual been immunized against hepatitis B Virus? Yes No Dates of Immunization: (1) / / (2) / / (3) / / Place where exposure incident occurred: Department Work Area Date Time Did incident arise out of and in the course of University employment? Yes No Name of individual in charge of area where exposure occurred: List any witnesses present: Name Address Telephone Name Address Telephone Personal protective equipment in use at time of exposure: Exposure to: Blood Body fluid with visible blood Vaginal secretions Seminal fluid Internal body fluids (circle one) cerebrospinal, synovial, pleural, amniotic, pericardial, peritoneal Type of Exposure: Needlestick/sharps accident Device Type: Device Brand: Contact with mucous membranes (eyes, mouth, nose) Contact with skin (circle all that apply) broken, chapped, abraded, dermatitis, prolonged contact, extensive contact

Severity of Exposure: How much fluid? How long was exposure? How severe was the injury? Estimated time interval from exposure until medical evaluation: Source of Exposure: Source individual, if known: Name Address Telephone Is a blood sample from the source available? Yes No Is the source individual s HBV antigen/antibody status known? Yes No Is the source individual s HIV antibody status known? Yes No Describe Activity Leading to Exposure: Giving Injection Recapping needle Discarding needle Handling IV line Handling disposal box Cleaning blood spill Handling waste products Handling lab specimen Controlling bleeding Performing invasive procedure Other: Precisely Describe Situation: Describe immediate interventions: Was the area washed flushed? Other: Did injury bleed freely? Yes No Was antiseptic applied? Yes No Describe nature and scope of personal injury, if any: Was medical treatment obtained: Yes No Hospital, physician or clinic where injured person was taken, if applicable: Name Address Person completing form: Name Job title/occupation Work telephone Home telephone Signature Date Attachment 2, OECP, SIU-SM

COUNSELING CHECKLIST FOR BLOOD AND/OR BODY FLUID EXPOSURE 1. Risk of transmission associated with exposure. 2. Facts about Hepatitis B Virus and Human Immunodeficiency Virus. 3. Symptoms to report. 4. Recommendation for prevention of transmission (no donating blood, organs, sperm; no sex/safe sex; avoid pregnancy and breast feeding for recommended time). 5. Resources available for further counseling/information. 6. Information and recommendations about Human Immunodeficiency Virus antibody testing and Hepatitis B prophylaxis and testing. 7. Obtaining test reports. 8. Confidentiality. 9. Prevention of future exposures. 10. The right to consult a physician of choice for further follow-up counseling or for the purpose of obtaining information pertaining to current research or treatment that could be available. Attachment 4, OECP, SIU-SM 44

HEPATITIS B EXPOSURE INFORMATION You have been evaluated for exposure to Hepatitis B. Your treatment has been in accord with the SIUC Occupational Exposure Control Plan for exposure to Hepatitis B. Your risk of acquiring Hepatitis B has been minimized by this intervention. However, if you should develop any of the following signs or symptoms within six months of exposure, please call the SIU-SM Infection Control Nurse (545-8970) or the Infection Control Physician on duty (545-5880). 1. Jaundice (yellowing of the skin and/or eyes) 2. Fever (greater than 101 o F or 38.2 o C) 3. Anorexia (loss of appetite) 4. Fatigue, malaise or lassitude (feeling tired for an extended period) 5. Nausea or vomiting 6. Diarrhea 7. Joint pain 8. Right upper abdomen or epigastric pain 9. Myalgia (sore muscles) Date of Exposure: Signature: Employee I.D. #: Printed Name: Witness: Attachment 5, OECP, SIU-SM 45

BLOODBORNE PATHOGEN EXPOSURE INCIDENT HEALTHCARE PROFESSIONAL S WRITTEN OPINION HBV Vaccination indicated? Yes No HBV Vaccination received? Yes No Date Received: On, was evaluated by SIU-SM Infection Date Name Control personnel, following an occupational exposure to human blood or other potentially infectious materials. He/she has been informed of the results of the post-exposure evaluation and has been advised of any medical conditions resulting from the exposure incident that require further evaluation or treatment. Signature Job Title Date Attachment 7, OECP, SIU-SM 47

SOURCE PATIENT INFORMATION Source Name: Work Phone: Home Phone: Address: Medical Record #: Room #: Hospital: Date of Birth: Primary Care/Attending Physician: Diagnosis: Source Risk Factors (as documented in medical record or patient interview): Yes No Unknown Known HIV Positive Yes No Unknown Known homosexual, bisexual, prostitute, or sexual contact with same Yes No Unknown Known IV drug user or history of same Yes No Unknown Received blood transfusion 1977 1985 Yes No Unknown Currently taking Zidovudine (AZT), Lamiduvine (3TC), and/or Indinivir (IDV) Yes No Unknown History of Hepatitis B, past, present or carrier Yes No Unknown History of Hepatitis C, past, present or carrier Yes No Unknown History of hemophilia, kidney, dialysis, transplant Yes No Unknown Currently elevated liver enzymes Yes No Unknown Current fever, lympyhadenopathy, rash, malaise, GI or neuro symptoms Yes No Unknown Traveled outside of the United States If yes, when and to which countries: Signature of individual preparing form Date